Global Single Use Bioprocessing Market Overview:
According to SPER Market Research, the single use bioprocessing market estimated to reach USD 35.1 billion by 2030 with a CAGR of 16.9%. Prevalence of chronic diseases is rising globally, requiring developments of new and large-scale production of biopharmaceutical products. Single use bioprocessing equipment assist in large scale production of such products at a lower cost.
Impact of COVID-19 on the Single Use Bioprocessing Market
COVID-19 pandemic prompted the discovery and development of vaccines for immunization against coronavirus. Many pharmaceutical and biopharmaceutical companies along with small startup companies have stepped forward into development of vaccines. Once these vaccines pass the clinical trials, they get the approval for marketing their product which requires large scale production. To achieve this, single-use equipment and systems are used. This has impacted the single use bioprocessing market positively.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2019-2030 |
| Base year considered | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | By Product, By Application, By End User
|
| Geographies covered | North America, Europe, APAC, Latin America and the Middle East & Africa |
| Companies Covered | ABEC, Inc., Able Corporation & Biott Corporation, Avantor, bbi-biotech GmbH, Cellexus, Celltainer Biotech, CESCO Bioengineering Co. Ltd., Corning, Danaher Corporation, Distek, Inc., Entegris, Eppendorf AG, G&G Technologies, Getinge AB, Kuhner AG, Meissner Filtration Products, Inc., Merck KGaA, OmniBRx Biotechnologies, PBS Biotech, Inc., Pierre Guerin, Sartorius Stedim Biotech S.A., Satake Chemical Equipment Mfg., Ltd., Solida Biotech GmbH, Stobbe Pharma GmbH, Thermo Fisher Scientific
|
Driver: Rising adoption of biopharmaceutical products
With rising global geriatric population, prevalence and incidence for chronic health conditions will increase. This will create demand for single-use bioprocessing systems for better efficiency, reduced costs and wide range of applications for development and manufacturing of biopharmaceutical products.
Restraints: Contamination risk from leachable
Single use bioprocessing is susceptible to leaching from closures, containers or solvents which can contaminate the end product compromising with the quality and safety. There is lack of regulations for the control of contaminants leaching from single use bioprocessing systems. Such concerns can restraint the growth of this market owing to health-related risks associated with contaminated biopharmaceutical products manufactured via these systems.
Opportunity: Growth potential in emerging economies
Emerging economies such as China, India have a huge potential for growth of single use bioprocessing market. The growth in this region is contributed by favourable government initiatives, increasing geriatric population, increasing investments by private shareholders and presence of highly skilled technicians who can handle the entire bioprocessing stages.
Challenge: Waste material disposal
The single-use bioprocessing provides cost reduction, faster manufacture and low capital investment. However, the amount of waste generated from such equipment is challenging to dispose. The single-use bioprocessor equipment are composed of many layers of plastic which is difficult to separate for disposal. The components are not biodegradable or suitable for recycling which leads to the production of plastic waste.
Single-use Bioprocessing Market Segmentation:
By Product: Based on product, market has been segmented into Single-use media bags and containers, Single-use assemblies, Single-use bioreactors, Disposable mixers, other products.
By Application: Based on application, market has been segmented into Filtration, Storage, Cell culture, Mixing, Purification.
By End User: Based on end user, the market is segmented into Biopharmaceutical & Pharmaceutical companies, Contract Research Organizations and contract manufacturing organizations (CROs & CMOs), Academic & Research institutes.
Biopharmaceutical & Pharmaceutical companies have the largest share of this market by end user due to rising demand for vaccines, rising installation of single-use bioprocessor and rising investments in single-use bioprocessing by biopharmaceutical and pharmaceutical companies.
By Region: North America owns the largest share of this market due to factors such as presence of leading players in this region, rising funding for R & D activities and rising trend for investments in single-use bioprocessing.
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Single Use Bioprocessing Market
4.4. Market Trends
5. Global Single Use Bioprocessing Market, By Product, 2019-2030 (USD Million)
5.1. Single-use media bags and containers
5.2. Single-use assemblies
5.3. Single-use bioreactors
5.4. Disposable mixers
5.5. Other products
6. Global Single Use Bioprocessing Market, By Application, 2019-2030 (USD Million)
6.1. Filtration
6.2. Storage
6.3. Cell culture
6.4. Mixing
6.5. Purification
7. Global Single Use Bioprocessing Market, By End User, 2019-2030 (USD Million)
7.1. Biopharmaceutical & Pharmaceutical companies
7.2. Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
7.3. Academic & Research institutes
8. Global Single Use Bioprocessing Market, By Geography, 2019-2030 (USD Million)
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. UK
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Latin America
8.4.2. Middle East & Africa
9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments
10. Company Profiles
10.1. ABEC, Inc.
10.2. Able Corporation & Biott Corporation
10.3. Avantor
10.4. bbi-biotech GmbH
10.5. Cellexus
10.6. Celltainer Biotech
10.7. CESCO Bioengineering Co. Ltd.
10.8. Corning
10.9. Danaher Corporation
10.10. Distek, Inc.
10.11. Entegris
10.12. Eppendorf AG
10.13. G&G Technologies
10.14. Getinge AB
10.15. Kuhner AG
10.16. Meissner Filtration Products, Inc.
10.17. Merck KGaA
10.18. OmniBRx Biotechnologies
10.19. PBS Biotech, Inc.
10.20. Pierre Guerin
10.21. Sartorius Stedim Biotech S.A.
10.22. Satake Chemical Equipment Mfg., Ltd.
10.23. Solida Biotech GmbH
10.24. Stobbe Pharma GmbH
10.25. Thermo Fisher Scientific